keyword
https://read.qxmd.com/read/38483611/efficacy-durability-and-safety-of-faricimab-up-to-every-16-weeks-in-patients-with-neovascular-age-related-macular-degeneration-2-year-results-from-the-japan-subgroup-of-the-phase-iii-tenaya-trial
#1
JOURNAL ARTICLE
Hideki Koizumi, Fumi Gomi, Akitaka Tsujikawa, Shigeru Honda, Ryusaburo Mori, Haruka Ochi, Keisuke Iwasaki, Annabelle Ayame Okada
PURPOSE: To evaluate 2-year efficacy, durability, and safety of faricimab in the TENAYA Japan subgroup and pooled global TENAYA/LUCERNE cohort of patients with neovascular age-related macular degeneration (nAMD). METHODS: Subgroup analysis of TENAYA/LUCERNE (NCT03823287/NCT03823300): phase III, multicentre, randomised, active comparator-controlled, double-masked, non-inferiority trials. Treatment-naïve patients aged ≥ 50 years with nAMD were randomised (1:1) to intravitreal faricimab (6...
March 14, 2024: Graefe's Archive for Clinical and Experimental Ophthalmology
https://read.qxmd.com/read/38452795/optical-coherence-tomography-angiography-in-the-diagnosis-of-ocular-disease
#2
REVIEW
Michael Kalloniatis, Henrietta Wang, Jack Phu, Janelle Tong, James Armitage
Clinical imaging provided by optical coherence tomography (OCT) and its variant, OCT-angiography (OCT-A), has revolutionised eyecare practice. The imaging techniques allow for the identification and quantification of ocular structures, supporting the diagnosis and prognosis of eye disease. In this review, an overview of the usefulness of OCT-A imaging in the diagnosis and management of a range of ocular conditions is provided when used in isolation or in combination with other imaging modalities and measures of visual function (visual field results)...
March 7, 2024: Clinical & Experimental Optometry: Journal of the Australian Optometrical Association
https://read.qxmd.com/read/38160737/subretinal-hyperreflective-material-shrm-in-retinal-and-chorioretinal-disorders-a-comprehensive-review
#3
REVIEW
Alessandro Feo, Elisa Stradiotto, Riccardo Sacconi, Matteo Menean, Giuseppe Querques, Mario R Romano
Subretinal hyperreflective material (SHRM) is a common and remarkable optical coherence tomography (OCT) biomarker whose importance is emerging in several retinal and chorioretinal diseases, including age-related macular degeneration, central serous chorioretinopathy, polypoidal choroidal vasculopathy, pathologic myopia, posterior uveitis, vitelliform lesions and macular dystrophies, and more rare disorders. Multimodal imaging, also thanks to the introduction of OCT angiography, allowed a deeper characterisation of SHRM components and its morphological changes after treatment, suggesting its usefulness in clinical practice...
December 29, 2023: Survey of Ophthalmology
https://read.qxmd.com/read/37996249/central-serous-chorioretinopathy-a-review
#4
JOURNAL ARTICLE
K Myslík Manethová
Central serous chorioretinopathy (CSC) is a disease characterized by serous detachment of the neuroretina, especially in the posterior pole of the eye. It is often accompanied by serous detachment of the retinal pigment epithelium (RPE) and associated with the leakage of fluid into the subretinal space through the defective RPE. CSC most often affects men of working age. The exact pathophysiology of the disease is not completely known. Based on indocyanine green angiography (ICG), which revealed increased permeability of choroidal vessels, and optical coherence tomography (OCT) showing increased choroidal thickness, choroidal vasculopathy is assumed to be the primary cause of CSC...
2023: Ceská a Slovenská Oftalmologie
https://read.qxmd.com/read/37980398/intravitreal-anti-vascular-endothelial-growth-factor-injections-in-pregnancy-and-breastfeeding-a-case-series-and-systematic-review-of-the-literature
#5
JOURNAL ARTICLE
Ariel Yuhan Ong, Christine A Kiire, Charlotte Frise, Yasmin Bakr, Samantha R de Silva
INTRODUCTION: Anti-vascular endothelial growth factor (anti-VEGF) agents may occasionally need to be considered for sight-threatening macular pathology in pregnant and breastfeeding women. This is controversial due to the dearth of data on systemic side effects for mother and child. We aimed to expand the evidence base to inform management. METHODS: Retrospective case series of pregnant and breastfeeding women treated with intravitreal anti-VEGF injections at Oxford Eye Hospital between January 2015 and December 2022...
November 18, 2023: Eye
https://read.qxmd.com/read/37903558/evaluation-of-a-self-imaging-oct-for-remote-diagnosis-and-monitoring-of-retinal-diseases
#6
JOURNAL ARTICLE
Zitian Liu, Wenyong Huang, Zhenyu Wang, Ling Jin, Nathan Congdon, Yingfeng Zheng, Shida Chen, Yizhi Liu
OBJECTIVES: To evaluate the feasibility and accuracy of a portable, self-imaging optical coherence tomography (OCT) for measuring central subfield thickness (CST) and achieving diagnostic concordance for retinal lesions compared with clinic-based spectral-domain OCT (SD-OCT). METHODS: This comparative, cross-sectional study was conducted between August 2020 and February 2021. Two groups of adult participants were recruited: (1) a selected cohort of 160 participants with confirmed diagnosis and (2) a consecutive cohort of 315 participants recruited randomly...
October 30, 2023: British Journal of Ophthalmology
https://read.qxmd.com/read/37865470/pegcetacoplan-for-the-treatment-of-geographic-atrophy-secondary-to-age-related-macular-degeneration-oaks-and-derby-two-multicentre-randomised-double-masked-sham-controlled-phase-3-trials
#7
RANDOMIZED CONTROLLED TRIAL
Jeffrey S Heier, Eleonora M Lad, Frank G Holz, Philip J Rosenfeld, Robyn H Guymer, David Boyer, Federico Grossi, Caroline R Baumal, Jean-Francois Korobelnik, Jason S Slakter, Nadia K Waheed, Ravi Metlapally, Ian Pearce, Nathan Steinle, Anibal A Francone, Allen Hu, David R Lally, Pascal Deschatelets, Cedric Francois, Caleb Bliss, Giovanni Staurenghi, Jordi Monés, Rishi P Singh, Ramiro Ribeiro, Charles C Wykoff
BACKGROUND: Geographic atrophy is a leading cause of progressive, irreversible vision loss. The objectives of OAKS and DERBY were to assess the efficacy and safety of pegcetacoplan compared with sham treatment in patients with geographic atrophy. METHODS: OAKS and DERBY were two 24-month, multicentre, randomised, double-masked, sham-controlled, phase 3 studies, in which patients aged 60 years and older with geographic atrophy secondary to age-related macular degeneration were enrolled at 110 clinical sites and 122 clinical sites worldwide, respectively...
October 21, 2023: Lancet
https://read.qxmd.com/read/37845140/aneurysmal-type-2-neovascularization-a-new-entity
#8
JOURNAL ARTICLE
J Montero-Hernández, L Remolí-Sargues, C Monferrer-Adsuara, V Castro-Navarro, C Navarro-Palop, E Cervera-Taulet
PURPOSE: To report three cases of aneurysmal type 2 neovascularization (AT2), a novel entity within the pachychoroid disease (PD) spectrum. METHODS: We conducted an observational retrospective study of three patients with subretinal polyps treated with intravitreal aflibercept. We reviewed clinical and imaging data of the three patients. Best corrected visual acuity (BCVA), central macular thickness (CMT), choroidal subfoveal thickness, choroidal thickness under the polyps and the presence of a dry macula were assessed at baseline and throughout the follow-up...
October 14, 2023: Journal Français D'ophtalmologie
https://read.qxmd.com/read/37816549/recurrence-risk-of-myopic-choroidal-neovascularisation-a-systematic-review-of-current-study
#9
JOURNAL ARTICLE
Andi Arus Victor, Gitalisa Andayani, Ari Djatikusumo, Anggun Rama Yudantha, Mario Marbungaran Hutapea, Seruni Hanna Ardhia, Kemal Akbar Suryoadji
INTRODUCTION: The rising prevalence of myopia is a concern in ophthalmology, with myopic choroidal neovascularisation (m-CNV) significantly affecting vision. However, long-term outcomes of m-CNV management have been unsatisfactory, leading to high recurrence rates. These studies aim to identify risk factors for m-CNV recurrence. METHODS: Comprehensive review followed a pre-registered plan in the International Prospective Register of Systematic Reviews (PROSPERO)...
October 2023: BMJ Open Ophthalmology
https://read.qxmd.com/read/37715860/evaluating-the-effects-of-c3-inhibition-on-geographic-atrophy-progression-from-deep-learning-oct-quantification-a-split-person-study
#10
JOURNAL ARTICLE
Dun Jack Fu, Veronika Lipkova, Bart Liefers, Sophie Glinton, Livia Faes, Alex McKeown, Lukas Scheibler, Nikolas Pontikos, Praveen J Patel, Gongyu Zhang, Pearse A Keane, Konstantinos Balaskas
INTRODUCTION: To evaluate the effect pegcetacoplan, a C3 and C3b inhibitor, on the rate of progression of geographic atrophy (GA) as assessed by spectral domain optical coherence tomography (SD-OCT) using a split-person study design and deep-learning quantification. METHODS: A post hoc analysis of phase 2 FILLY trial data comparing study (treated monthly, treated every other month and sham-treated) and fellow (untreated) eyes in a split-person study design was performed...
September 16, 2023: Ophthalmology and Therapy
https://read.qxmd.com/read/37658033/predictors-of-stoppage-and-recurrence-of-choroidal-neovascularization-with-a-treat-extend-stop-protocol-4-year-follow-up
#11
JOURNAL ARTICLE
G Garay-Aramburu, D Rodriguez-Feijoo, M Aldazabal-Echeveste, Z Del Barrio, A Eiras-Fernández, D P Piñero, A Larrauri-Arana
OBJECTIVE: To analyze the long-term results of treatment of active age-related macular degeneration (AMD) with anti-vascular endothelial growth factor (VEGF) agents using the treat-extend-stop (TES) approach, defining predictive factors for stoppage of the treatment and recurrences in a real-world setting. METHODS: Data from 191 eyes treated with intravitreal injections for choroidal neovascularization due to AMD were retrospectively reviewed. Changes in best-corrected visual acuity (BCVA) and membrane activity (optical coherence tomography) were recorded and evaluated over a 48-month follow-up...
August 30, 2023: Journal Français D'ophtalmologie
https://read.qxmd.com/read/37652172/punctate-inner-choroidopathy-in-common-variable-immunodeficiency-associated-with-a-pathogenic-variant-in-the-tumour-necrosis-factor-receptor-superfamily-13b-tnfrsf13b-gene-case-report-and-review-of-the-literature
#12
JOURNAL ARTICLE
Hiba Salih, Kelvin Cheng Kah Wai, Justin McKee, Charu Chopra
BACKGROUND: Common variable immunodeficiency (CVID) has been recognised as the most common primary immunodeficiency in adulthood, and is characterised by increased susceptibility to infection, autoimmunity and increased risk of malignancies. Although ocular manifestations are not common in CVID, rare associated inflammatory eye conditions have been reported including submacular choroiditis. OBJECTIVE: To report a case of punctate inner choroidopathy in a patient with common variable immunodeficiency...
August 29, 2023: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/37544613/macular-neovascularization-in-inherited-retinal-diseases-a-review
#13
REVIEW
Rachael C Heath Jeffery, Fred K Chen
Inherited retinal diseases (IRDs) are the most common cause of blindness in working-age adults. Macular neovascularization (MNV) may be a presenting feature or occurs as a late-stage complication in several IRDs. We performed an extensive literature review on MNV associated with IRDs. MNV is a well-known complication of Sorsby fundus dystrophy and pseudoxanthoma elasticum. Those with late-onset Stargardt disease may masquerade as exudative age-related macular degeneration (AMD) when MNV is the presenting feature...
August 6, 2023: Survey of Ophthalmology
https://read.qxmd.com/read/37474162/comparison-of-antivascular-endothelial-growth-factor-treatment-for-myopia-choroidal-neovascularisation-a-systematic-review-and-meta-analysis-of-randomised-controlled-trials
#14
JOURNAL ARTICLE
Liming Dong, Guangyao Li, Zhihui Song, Xiao Cheng, Jie Bai, Chao Zhang
OBJECTIVES: To evaluate the efficacy and safety of anti-vascular endothelial growth factor (anti-VEGF) therapy for myopia choroidal neovascularisation (CNV), and to compare the efficacy of two different anti-VEGF retreatment criteria. DATA SOURCES: PubMed, EMBASE, the Cochrane Library and ClinicalTrials.gov were searched from inception to 31 July 2022. STUDY SELECTION: Randomised controlled trials (RCTs) comparing anti-VEGF with sham, photodynamic therapy (PDT) or PDT combination therapy in patients with myopia CNV were reviewed and selected...
July 20, 2023: BMJ Open
https://read.qxmd.com/read/37330004/role-of-hif1a-and-hif2a-in-cre-recombinase-induced-retinal-pigment-epithelium-pathology-and-its-secondary-effect-on-choroidal-neovascularisation
#15
JOURNAL ARTICLE
Enrico Cristante, Sidath E Liyanage, Alexander J Smith, Robin R Ali, James W B Bainbridge
CreTrp1 mice are widely used for conditional retinal pigment epithelium (RPE) gene function studies. Like other Cre/LoxP models, phenotypes in CreTrp1 mice can be affected by Cre-mediated cellular toxicity, leading to RPE dysfunction, altered morphology and atrophy, activation of innate immunity and consequent impairment of photoreceptor function. These effects are common to the age-related alterations of RPE that feature in early/intermediate forms of age-related macular degeneration. This manuscript characterises Cre-mediated pathology in the CreTrp1 line to elucidate the impact of RPE degeneration on both developmental and pathological choroidal neovascularization...
June 15, 2023: American Journal of Pathology
https://read.qxmd.com/read/37176543/scleral-thickness-as-a-risk-factor-for-central-serous-chorioretinopathy-and-pachychoroid-neovasculopathy
#16
JOURNAL ARTICLE
Leonie F Keidel, Benedikt Schworm, Julian Langer, Nikolaus Luft, Tina Herold, Felix Hagenau, Julian E Klaas, Siegfried G Priglinger, Jakob Siedlecki
In the pathophysiology of central serous chorioretinopathy (CSC), scleral changes inducing increased venous outflow resistance are hypothesized to be involved. This work aims to investigate anterior scleral thickness (AST) as a risk factor for pachychoroid disorders. A randomized prospective case-control study was performed at the Ludwig Maximilians University, Department of Ophthalmology. In patients with CSC or pachychoroid neovasculopathy (PNV) and in an age- and refraction-matched control group, swept source optical coherence tomography (SS-OCT) was used to measure anterior scleral thickness (AST)...
April 24, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37111251/half-fluence-half-dose-photodynamic-therapy-less-direct-damage-but-more-inflammation
#17
Thomas Desmettre, Martin A Mainster, Gerardo Ledesma-Gil
Objective: To present clinical findings and multimodal imaging of three patients who developed bacillary layer detachments (BALADs) shortly after half-fluence, half-dose (HFHD) verteporfin photodynamic therapy (PDT). Methods: Retrospective observational case series. Three patients were treated with HFHD-PDT for (1) macular neovascularisation five years after resolved central serous chorioretinopathy (CSC), (2) persistent serous retinal detachment (SRD) from chronic CSC, and (3) neovascular age-related macular degeneration with persistent SRD despite intravitreal anti-VEGF therapy...
March 27, 2023: Pharmaceuticals
https://read.qxmd.com/read/37046527/cnv-net-segmentation-classification-and-activity-score-measurement-of-choroidal-neovascularization-cnv-using-optical-coherence-tomography-angiography-octa
#18
JOURNAL ARTICLE
Mahsa Vali, Behzad Nazari, Saeed Sadri, Elias Khalili Pour, Hamid Riazi-Esfahani, Hooshang Faghihi, Nazanin Ebrahimiadib, Momeneh Azizkhani, Will Innes, David H Steel, Anya Hurlbert, Jenny C A Read, Rahele Kafieh
This paper aims to present an artificial intelligence-based algorithm for the automated segmentation of Choroidal Neovascularization (CNV) areas and to identify the presence or absence of CNV activity criteria (branching, peripheral arcade, dark halo, shape, loop and anastomoses) in OCTA images. Methods: This retrospective and cross-sectional study includes 130 OCTA images from 101 patients with treatment-naïve CNV. At baseline, OCTA volumes of 6 × 6 mm2 were obtained to develop an AI-based algorithm to evaluate the CNV activity based on five activity criteria, including tiny branching vessels, anastomoses and loops, peripheral arcades, and perilesional hypointense halos...
March 31, 2023: Diagnostics
https://read.qxmd.com/read/36884066/-photodynamic-therapy-in-germany-quo-vadis
#19
JOURNAL ARTICLE
L Pauleikhoff, K Rothaus, F Groß-Bölting, D Böhringer, J Lübke, H Agostini, C Lange
BACKGROUND: Photodynamic therapy (PDT) was originally approved for the treatment of neovascular age-related macular degeneration (nAMD) and secondary choroidal neovascularization in myopia (mCNV). In addition, it is used as an off-label treatment in patients with choroidal hemangioma, polypoidal choroidal vasculopathy (PCV), and central serous chorioretinopathy (CSC). OBJECTIVE: To track the development of PDT treatment numbers in Germany between 2006 and 2021 and to investigate the composition of the therapeutic indications...
March 8, 2023: Ophthalmologie
https://read.qxmd.com/read/36746135/long-term-outcomes-of-high-dose-conbercept-treatment-for-myopic-cho-roidal-neovascularisation-and-idiopathic-choroidal-neovascularisation
#20
JOURNAL ARTICLE
Wei Zhu, Yanlei Hao, Zhongfang Yuan, Chunmei Huang, Jiehui Liu, Yan Ma
INTRODUCTION: To report 2-year outcomes of intravitreal injection of high-dose conbercept (1 mg 2+PRN scheme) for subjects with myopic choroidal neovascularization (mCNV) and idiopathic choroidal neovascularization (iCNV) by optical coherence tomography angi-ography (OCTA) follow-up. METHODS: A total of 38 subjects (38 eyes) were enrolled in this retrospective study, which were divided into group A (mCNV, 20 subjects, 20 eyes) and group B (iCNV, 18 subjects,18 eyes)...
February 6, 2023: Ophthalmic Research
keyword
keyword
102387
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.